Evidence for Increased SOX3 Dosage as a Risk Factor for X-Linked Hypopituitarism and Neural Tube Defects

Marijke Bauters, Suzanna G. Frints, Hilde Van Esch, Liesbeth Spruijt, Marcella M. Baldewijns, Christine E. M. de Die-Smulders, Jean-Pierre Fryns, Peter Marynen, Guy Froyen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1947-1952
JournalAmerican Journal of Medical Genetics Part A
Volume164
Issue number8
DOIs
Publication statusPublished - Aug 2014

Keywords

  • X-linked hypopituitarism
  • growth hormone deficiency
  • SOX3 duplication
  • neural tube defect
  • gene overexpression

Cite this

Bauters, M., Frints, S. G., Van Esch, H., Spruijt, L., Baldewijns, M. M., de Die-Smulders, C. E. M., Fryns, J-P., Marynen, P., & Froyen, G. (2014). Evidence for Increased SOX3 Dosage as a Risk Factor for X-Linked Hypopituitarism and Neural Tube Defects. American Journal of Medical Genetics Part A, 164(8), 1947-1952. https://doi.org/10.1002/ajmg.a.36580